Exploring Non-Opioid Post-Operative Pain Management Strategies for Third Molar Surgery
Researchers reviewed alternative and complementary therapies for postoperative pain management in patients undergoing lower third molar surgery.
Read More
Dissemination (Meeting Coverage)
AAOMS 2024 On-Demand Sessions
This years AAOMS annual meeting will include on-demand sessions that will be available starting on September 9, 2024.
Read More
Will You Be Playing AAOMSopoly Game?
Back by popular demand! Attendees are invited to join the fun by participating in AAOMSopoly, an exciting Exhibit Hall game available on the Annual Meeting mobile app.
Read More
CTNNB1 Alterations Affect Outcomes in Patients With HCC
CTNNB1 alterations affect outcomes in patients with hepatocellular carcinoma (HCC).
Read More
Why Do Physicians Order NSCLC Biomarker Tests, and Who Gets Appropriate Targeted Therapy?
Biomarker tests for non-small lung cancer (NSCLC) improve patient outcomes, but they are not available to everyone.
Read More
Targeted Sequencing Adds Value to FISH for Detecting Genetic Alterations in CLL
Researchers evaluated whether targeted next-generation sequencing was comparable to fluorescence in situ hybridization for detecting genetic alterations in CLL.
Read More
Adding a Kinase to Pembrolizumab May Increase CLL Treatment Efficacy
Adding BCR kinase inhibitor ibrutinib or idelalisib to monoclonal antibody pembrolizumab increases treatment efficacy in CLL with Richter transformation.
Read More
Molecular Testing Appears To Be Increasing in eNSCLC
An increasing number of patients with eNSCLC currently have access to biomarker testing and targeted therapies, according to the MYLUNG consortium.
Read More
Black Patients With HCC Less Likely to Receive Curative Treatment
Black patients with HCC are less likely than White patients to receive curative treatment.
Read More
High-Dose Melphalan Conditioning Benefits Patients With Multiple Myeloma
High-dose melphalan conditioning confers survival benefits in patients with extramedullary and non-extramedullary multiple myeloma.
Read More
Targeted Interventions Benefit African Americans With Multiple Myeloma
African Americans benefit from targeted multiple myeloma interventions.
Read More
AI’s Increasing Capacity to Outperform Human Detection of Lung Cancer
AI detects lung cancer better than humans do.
Read More
Understanding the Needs of Patients With Hepatocellular Carcinoma & Their Caregivers
While patients with hepatocellular carcinoma largely felt independent, their caregivers reported burdens related to appointment logistics and emotional support.
Read More
Evaluating Safety & Outcomes of Rapid BCL-2 Inhibitor Titration for CLL
Researchers at the 2024 ASCO Annual Meeting studied the rapid titration of venetoclax for chronic lymphocytic leukemia and mantle cell lymphoma.
Read More
Multiple Myeloma Linked to Higher Costs & Mortality in Patients Admitted for GI Bleeding
Patients with multiple myeloma who were admitted for gastrointestinal bleeding had higher costs and mortality than those without multiple myeloma.
Read More
Ultrasensitive Circulating Tumor DNA Improves NSCLC Detection
Ultrasensitive Circulating Tumor DNA improves clinical sensitivity of minimal residual disease in early stage non-small cell lung cancer.
Read More
ALBI Grade, MVI, & Distant Metastases Predict Survival in HCC
HCC survival time is predicted by albumin-bilirubin grade, microvascular invasion, and distant metastases.
Read More
Barriers to Care Delay Costly Multiple Myeloma Treatment
Social determinants of health create barriers that delay access to expensive oral anti-myeloma drugs for people with newly diagnosed multiple myeloma.
Read More
AI and ML Show Promise in Targeting Therapies for Chronic Lymphocytic Leukemia
AI and ML advances chronic lymphocytic leukemia therapies.
Read More
Correlation of Treatment Response with PFS and OS in Patients with R/R CLL or SLL
The following is a summary of “Association between treatment (tx) response and PFS and OS in R/R...
Read More